ClinicalTrials.gov
public full text
Public Domain
TearCare MGX™ System With and Without Warming Hold
TearCare is an office-based thermal therapeutic eyelid technology cleared by the US Food and Drug Administration for the treatment of evaporative dry eye disease due to meibomian gland dysfunction. In this randomized study, TearCare procedures using the TearCare MGX System (study device) with the extended Warming hold feature will be compared with TearCare procedures using the TearCare MGX System without the Warming hold (control group).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Effect of an Eyelid Warming Device for the Management of Meibomian Gland Dysfunction#1162981
- Treatment of Meibomian Gland Dysfunction#1046085
- Impact of Tixel Treatment on Symptoms and Signs in Patients With Dry Eye Disease#893686
- Effects of P-TIOX and Tixel Combined on Reducing Eye Wrinkles#1127716
- Efficacy of IPL Treatment of Dry Eye and Ocular Rosacea#801960
Record · ID 1047737
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive